CLINICAL_TRIALS
trial_result
· 2024-08-22
Clinical Trial Update: Safety and Immunogenicity of a Chlamydia Vaccine CTH522 [Phase 1]
Summary
A Phase 1 trial assessing the safety and immunogenicity of the Chlamydia vaccine CTH522 for Trachoma has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Statens Serum Institut | Conditions: Trachoma | Phase 1 | Status: COMPLETED | Results posted: 2024-08-22